Scientific publications




  • Pragmatic and profound benefits of Acyclovir Buccal adhesive tablets
    « Results of pivotal trials indicate that usage, starting within one hour of prodrome ontset, can hasten episode resolution, reduce time to healing of primary lesion, reduce the number of future outbreaks, and increase the time between subsequent outbreaks. »
    Published in « Journal of Drugs in Dermatology (JDD) », June 2016



  • Plasma, saliva and labial mucosa pharmacokinetics and pharmacodynamics of acyclovir Lauriad® mucoadhesive buccal tablet in healthy volunteers
    « The ABT delivery system provides earlier, higher and more sustained concentrations of acyclovir than acyclovir 200 mg oral tablet in saliva and mucosa. »
    Published in « Journal of Clinical Pharmacology & Clinical Pharmacokinetics », March 7 2014


  • Mouth to Mouth
    « Prolonging the residence time of drugs administered topically in the oral cavity is a major challenge. This has been overcome with the developement of mucoadhesive buccal tablets with sustained release properties. »
    Published in ebr, July 2014